Determining the preventive effect of venous fibrinogen on the amount of bleeding during hip arthroplasty surgery
Phase 3
- Conditions
- Total hip arthroplasty.
- Registration Number
- IRCT20120910010800N3
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
over than 18 years old
Consent to the study
Exclusion Criteria
Drug abuse
Existence of uncontrolled underlying disease
History of any previous surgery within the field of the current operation
Recent history of coagulation disease
Taking drugs that affect blood clotting before hospitalization
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bleeding during surgery. Timepoint: End of surgery. Method of measurement: The amount of bleeding during the operation will be measured by gas count and suction measurement, as well as the estimation of bleeding at the operation site by an anesthesiologist.
- Secondary Outcome Measures
Name Time Method umber of units of injected blood products. Timepoint: Up to 24 hours after surgery. Method of measurement: Registration of blood products injection sheet.